Literature DB >> 20596670

Functional characterization of AIBp, a novel Aurora-A binding protein in centrosome structure and spindle formation.

Ann-Shung Lieu1, Tai-Shan Cheng, Chia-Hua Chou, Chia-Hung Wu, Chia-Yi Hsu, Chi-Ying F Huang, Li-Kwan Chang, Joon-Khim Loh, Chung-Shing Chang, Ching-Mei Hsu, Shen-Long Howng, Yi-Ren Hong.   

Abstract

Aurora-A is involved in chromosome alignment, centrosome maturation, mitotic spindle assembly and regards to an oncogene. Aurora-A is also known to bind to several other proteins affecting its up-regulation or down-regulation and localization. However, how these different binding signals work together to regulate Aurora-A is not properly known. To explore more Aurora-A interacting proteins, the low-copy yeast two-hybrid screening using Aurora-A as bait protein was performed. One novel gene, AIBp, was demonstrated to associate with Aurora-A by the yeast two-hybrid method and in vitro GST pull-down assay. Molecular characterization showed that AIBp possessed a binding site at the C-terminal with Aurora-A (kinase domain). Interestingly, AIBp also interacts with hNinein at the N-terminal, which overlaps with a previously reported hNinein and GSK3beta binding site. Using a kinase assay, AIBp interacts with the Aurora-A kinase domain functions as a positive regulator, whereas AIBp binding to hNinein appears to block the phosphorylation of hNinein by both Aurora-A and GSK3beta. siRNA-mediated elimination of AIBp from HeLa cells, results in a doughnut-like shape, asymmetrical spindle pole and multiple spindle pole formation. We also demonstrated that both AIBp and Aurora-A are co-overexpressed in various brain tumors. These studies demonstrate that AIBp may not only be required for the dynamic movement of Aurora-A at the centrosomes and spindle apparatus during the cell cycle, but may also be important during brain tumorigenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596670     DOI: 10.3892/ijo_00000691

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  6 in total

1.  JAK2 tyrosine kinase phosphorylates and is negatively regulated by centrosomal protein Ninein.

Authors:  Jennifer Jay; Alan Hammer; Andrea Nestor-Kalinoski; Maria Diakonova
Journal:  Mol Cell Biol       Date:  2014-10-20       Impact factor: 4.272

2.  AIBp regulates mitotic entry and mitotic spindle assembly by controlling activation of both Aurora-A and Plk1.

Authors:  Chia-Hua Chou; Joon-Khim Loh; Ming-Chang Yang; Ching-Chih Lin; Ming-Chang Hong; Chung-Lung Cho; An-Kuo Chou; Chi-Huei Wang; Ann-Shung Lieu; Shen-Long Howng; Ching-Mei Hsu; Yi-Ren Hong
Journal:  Cell Cycle       Date:  2015-06-26       Impact factor: 4.534

3.  AUNIP/C1orf135 directs DNA double-strand breaks towards the homologous recombination repair pathway.

Authors:  Jiangman Lou; Hongxia Chen; Jinhua Han; Hanqing He; Michael S Y Huen; Xin-Hua Feng; Ting Liu; Jun Huang
Journal:  Nat Commun       Date:  2017-10-17       Impact factor: 14.919

4.  Identification of AUNIP as a candidate diagnostic and prognostic biomarker for oral squamous cell carcinoma.

Authors:  Zongcheng Yang; Xiuming Liang; Yue Fu; Yingjiao Liu; Lixin Zheng; Fen Liu; Tongyu Li; Xiaolin Yin; Xu Qiao; Xin Xu
Journal:  EBioMedicine       Date:  2019-08-10       Impact factor: 8.143

5.  AUNIP Expression Is Correlated With Immune Infiltration and Is a Candidate Diagnostic and Prognostic Biomarker for Hepatocellular Carcinoma and Lung Adenocarcinoma.

Authors:  Chenxi Ma; Wenyan Kang; Lu Yu; Zongcheng Yang; Tian Ding
Journal:  Front Oncol       Date:  2020-12-09       Impact factor: 6.244

Review 6.  Deoxyribonucleic Acid Damage and Repair: Capitalizing on Our Understanding of the Mechanisms of Maintaining Genomic Integrity for Therapeutic Purposes.

Authors:  Jolene Michelle Helena; Anna Margaretha Joubert; Simone Grobbelaar; Elsie Magdalena Nolte; Marcel Nel; Michael Sean Pepper; Magdalena Coetzee; Anne Elisabeth Mercier
Journal:  Int J Mol Sci       Date:  2018-04-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.